Cargando…
A Case of De Novo Psoriasis Secondary to Nivolumab in a Patient With Metastatic Renal Cell Carcinoma
Immune-mediated adverse events are commonly seen with immune checkpoint inhibitors like nivolumab. Oncology specialists usually have to screen patients for risk factors for autoimmune diseases, since immune checkpoint inhibitors can potentially exacerbate these events. Some of the immune-mediated si...
Autores principales: | Mullangi, Sanjana, Ponnam, Sreeja, Lekkala, Manidhar Reddy, Koya, Supriya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288591/ https://www.ncbi.nlm.nih.gov/pubmed/34290912 http://dx.doi.org/10.7759/cureus.15703 |
Ejemplares similares
-
Epidemiology and Outcomes of Hospitalizations Due to Hepatocellular Carcinoma
por: Mullangi, Sanjana, et al.
Publicado: (2021) -
New-Onset Autoimmune Diabetes Mellitus Presenting As Diabetic Ketoacidosis in Association With Pembrolizumab Therapy and Long Term Follow-Up: Case Report
por: Pachpande, Vrushali, et al.
Publicado: (2022) -
Review of Bone Modifying Agents in Metastatic Breast Cancer
por: Raghu Subramanian, Charumathi, et al.
Publicado: (2021) -
Temporal Trends, Predictors, and Outcomes of Disseminated Intravascular Coagulation in Hospitalizations With Sepsis
por: Solanki, Dhanshree, et al.
Publicado: (2022) -
Incidental Finding of Squamous Cell Carcinoma on a 68Ga-DOTATATE PET Scan
por: Mullangi, Sanjana, et al.
Publicado: (2021)